Publications by authors named "Martin Mikusko"

Claim this Profile
C
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement.
Verena Keitel, Michael C Kreissl, Tobias Goetze, Carola Dröge, Christina Katharina Kuhn, Martin Mikusko

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Challenges in Acute Leukemia: From Dental Pain to Catastrophic Intracerebral Hemorrhage.
Anatoli Pinchuk, Stefan P Roch, Christian Mawrin, Daniel Behme, Klaus-Peter Stein, Martin Mikusko

Hematol Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells.
Karolin Trautmann-Grill, Malte von Bonin, Annabell Georgi, Jan Moritz Middeke, Martin Böttcher, Martin Mikusko

Lancet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parameters of body composition do not predict survival in patients with multiple myeloma undergoing autologous stem cell transplantation.
Felix Barajas Ordonez, Denise Wolleschak, Yannic Zeller, Mattes Hinnerichs, Pablo Rodríguez-Feria, Martin Mikusko

Leuk Lymphoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
Felix Barajas Ordonez, Yannic Zeller, Denise Wolleschak, Mattes Hinnerichs, Pablo Rodríguez-Feria, Martin Mikusko

Clin Nutr ESPEN· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial.
Othman Al-Sawaf, Rudy Ligtvoet, Sandra Robrecht, Janina Stumpf, Anna-Maria Fink, Martin Mikusko

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Alexey Surov, Maciej Pech, Daniel Gessner, Martin Mikusko, Thomas Fischer

Clin Nutr· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis